Cargando…
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro
An effective response to the ongoing coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) will involve a range of complementary preventive modalities. The current studies were conducted to evaluate the in vitro SARS-CoV-2 antiviral and viruci...
Autores principales: | Paull, Jeremy R.A., Heery, Graham P., Bobardt, Michael D., Castellarnau, Alex, Luscombe, Carolyn A., Fairley, Jacinth K., Gallay, Philippe A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Starpharma Pty Ltd. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126375/ https://www.ncbi.nlm.nih.gov/pubmed/34010661 http://dx.doi.org/10.1016/j.antiviral.2021.105089 |
Ejemplares similares
-
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
por: Paull, Jeremy R. A., et al.
Publicado: (2021) -
Astodrimer sodium antiviral nasal spray for reducing respiratory infections is safe and well tolerated in a randomized controlled trial
por: Castellarnau, Alex, et al.
Publicado: (2022) -
Topical Astodrimer Sodium, a Non-Toxic Polyanionic Dendrimer, Demonstrates Antiviral Activity in an Experimental Ocular Adenovirus Infection Model
por: Romanowski, Eric G., et al.
Publicado: (2021) -
A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis
por: Schwebke, Jane R., et al.
Publicado: (2021) -
A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis
por: Waldbaum, Arthur S., et al.
Publicado: (2020)